Andree Blaukat, PhD Senior Vice President- Head Translational Innovation Platform Oncology, Merck KGaA, Darmstadt
Prof. Dr. Stefan Fröhling Managing Director of the National Cancer Center, Heidelberg, Germany
Cornelis Melief, MD, PhD Emeritus Professor Internal Medicine, CSO of ISA Pharmaceuticals, Leiden
Ira Mellman, PhD Vice President Cancer Immunology at Genentech, San Francisco, CA, USA
Prof. Dr. Andreas Neubauer Director Hematology & Oncology, Universitätsklinikum Gießen/Marburg, Germany
Prof. Dr. Tobias Sjöblom Program Director for U-CAN (Biobank), Uppsala University, Sweden